[go: up one dir, main page]

DK1784173T3 - Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater - Google Patents

Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater

Info

Publication number
DK1784173T3
DK1784173T3 DK05756853.7T DK05756853T DK1784173T3 DK 1784173 T3 DK1784173 T3 DK 1784173T3 DK 05756853 T DK05756853 T DK 05756853T DK 1784173 T3 DK1784173 T3 DK 1784173T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
pharmaceutical composition
metabolic bone
bone disorders
Prior art date
Application number
DK05756853.7T
Other languages
English (en)
Inventor
Se-Won Kim
Seon-Yle Ko
Bum Tae Kim
Yong Ki Min
Yeon Soo Lee
Jung Nyoung Heo
Hyuk Lee
No Kyun Park
Jung-Keun Kim
Original Assignee
Korea Res Inst Chem Tech
Oscotec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Res Inst Chem Tech, Oscotec Inc filed Critical Korea Res Inst Chem Tech
Application granted granted Critical
Publication of DK1784173T3 publication Critical patent/DK1784173T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
DK05756853.7T 2004-06-22 2005-06-22 Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater DK1784173T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020040046644A KR100624238B1 (ko) 2004-06-22 2004-06-22 알파-아릴메톡시아크릴레이트 유도체를 함유하는 대사성골 질환의 예방 및 치료용 약학 조성물
PCT/KR2005/001935 WO2005123054A1 (en) 2004-06-22 2005-06-22 Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives

Publications (1)

Publication Number Publication Date
DK1784173T3 true DK1784173T3 (da) 2012-05-07

Family

ID=35509437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05756853.7T DK1784173T3 (da) 2004-06-22 2005-06-22 Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater

Country Status (9)

Country Link
US (2) US7879835B2 (da)
EP (1) EP1784173B1 (da)
JP (1) JP4733698B2 (da)
KR (1) KR100624238B1 (da)
CN (1) CN1968687B (da)
AT (1) ATE541567T1 (da)
DK (1) DK1784173T3 (da)
ES (1) ES2380454T3 (da)
WO (1) WO2005123054A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1310899C (zh) * 2003-11-11 2007-04-18 沈阳化工研究院 具有杀虫、杀菌活性的苯并吡喃酮类化合物及制备与应用
KR101426220B1 (ko) 2005-02-16 2014-08-05 아나코르 파마슈티칼스 인코포레이티드 보론함유 소분자
KR100720026B1 (ko) * 2005-06-22 2007-05-21 한국화학연구원 아미노 치환기를 갖는 알파-아릴메톡시아크릴레이트 유도체및 이를 함유하는 대사성 골 질환의 예방 및 치료용 약학조성물
MX335993B (es) * 2005-12-30 2016-01-07 Anacor Pharmaceuticals Inc Moleculas pequeñas que contienen boro.
CN106008583A (zh) 2005-12-30 2016-10-12 安纳考尔医药公司 含硼的小分子
BRPI0710209A2 (pt) * 2006-03-29 2011-05-24 Basf Se uso de derivados de estrobilurina, medicamento, e, processo para a preparação de um medicamento
CN101311170B (zh) * 2007-05-25 2010-09-15 中国中化股份有限公司 取代嘧啶醚类化合物及其应用
WO2009148874A2 (en) * 2008-05-29 2009-12-10 Osteogenex Inc. Gamma-lactam compounds for promoting bone growth
WO2011132967A2 (ko) 2010-04-21 2011-10-27 주식회사 오스코텍 알파-아릴메톡시아크릴레이트 유도체, 이의 제조방법 및 이를 포함하는 약학적 조성물
CN105037258A (zh) * 2015-06-17 2015-11-11 中化化工科学技术研究总院 杀菌剂啶氧菌酯原药中一种杂质的制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3889345T2 (de) * 1987-02-09 1994-09-01 Zeneca Ltd Schimmelbekämpfungsmittel.
EP0335519A1 (en) * 1988-03-31 1989-10-04 Imperial Chemical Industries Plc Insecticides
US5104872A (en) 1989-08-22 1992-04-14 Nihon Hohyaku Co., Ltd. N-(substituted benzyloxy) imine derivatives and method of use thereof
ES2120100T3 (es) 1990-06-27 1998-10-16 Basf Ag O-bencil-oximeteres y agentes protectores de las plantas que contienen estos compuestos.
NZ242290A (en) * 1991-04-15 1994-12-22 Zeneca Ltd Pyridyl and pyrimidinyl substituted oxime-o-benzyl ether derivatives; preparatory processes, fungicidal compositions and an intermediate
EP0741693B1 (en) * 1994-01-27 1999-03-24 Novartis AG Process for the preparation of arylacetic ester derivatives via palladium-catalyzed cross coupling reaction
ITMI20020814A1 (it) * 2002-04-17 2003-10-17 Isagro Ricerca Srl Nuovi analoghi delle strobilurine e loro uso quali acaricidi e insetticidi

Also Published As

Publication number Publication date
KR20050121491A (ko) 2005-12-27
EP1784173A1 (en) 2007-05-16
ATE541567T1 (de) 2012-02-15
JP2008503567A (ja) 2008-02-07
JP4733698B2 (ja) 2011-07-27
WO2005123054A1 (en) 2005-12-29
US20080280901A1 (en) 2008-11-13
CN1968687A (zh) 2007-05-23
EP1784173A4 (en) 2009-07-01
EP1784173B1 (en) 2012-01-18
ES2380454T3 (es) 2012-05-11
US8227456B2 (en) 2012-07-24
US20100256367A1 (en) 2010-10-07
KR100624238B1 (ko) 2006-09-19
US7879835B2 (en) 2011-02-01
CN1968687B (zh) 2013-11-06

Similar Documents

Publication Publication Date Title
NO2020031I1 (no) kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat
DK1656347T3 (da) Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
ATE517882T1 (de) Chinolinderivate
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
NO20090469L (no) Substituerte piperidiner som oker P53-aktiviteten, og anvendelse derav
EP1851237A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING BONE DISORDERS
TW200724543A (en) Heterocyclic compounds and their uses as therapeutic agents
ATE520668T1 (de) Sigmarezeptor-inhibitoren
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
TW200611695A (en) Pyrrolopyridine derivatives
UY28774A1 (es) Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes.
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
DK1784173T3 (da) Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
EA200702282A1 (ru) Комбинация феррохина и производного артемизинина для лечения малярии
ATE412636T1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
DK1853232T3 (da) Stabil krystallin form af bifeprunox mesylat, doseringsformer deraf og fremgangsmåder for deres anvendelse
TW200732304A (en) Piperidine derivatives
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
PL1732902T3 (pl) Pochodne nukleozydów i ich terapeutyczne zastosowanie
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors